NCT06547099View on ClinicalTrials.gov

Study to Understand Novel Biomarkers in Researching Dementia

RecruitingOBSERVATIONAL
Enrollment

1,800

Participants

Timeline

Start Date

August 14, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Alzheimer DiseaseMild Cognitive ImpairmentDementia
Interventions
DIAGNOSTIC_TEST

Clinical tau PET

Tau PET (flortaucipir)

DIAGNOSTIC_TEST

Clinical amyloid test

Amyloid PET (florbetapir), CSF amyloid test, or blood amyloid test

OTHER

Research blood collection

Research blood assays for amyloid, tau, and neurodegeneration

OTHER

Cognitive assessments

Clinical Dementia Rating (CDR) or electronic Clinical Dementia Rating (eCDR); Montreal Cognitive Assessment (MoCA)

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Washington University School of Medicine

OTHER